Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia

NCT06072040 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
3
Enrollment
INDUSTRY
Sponsor class

Stopped Business reasons

Conditions

Interventions

Sponsor

Auregen Biotherapeutics, SA